Caribou Biosciences
Berkeley · Founded 2011
About Caribou Biosciences
Caribou Biosciences is an operator of a medical technology company intended to analyze cell and genome engineering. The company specializes in cellular engineering and analysis based on the CRISPR-Cas9 technology platform which paired with a guide RNA, cuts double-stranded DNA and allows for specific changes to DNA, enabling the development of therapeutics for agricultural biotechnology, industrial biotechnology, and basic and applied biological research.
Company Facts
- Founded: 2011
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $317.7M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jul 2023)
- Ticker: nasdaq:CRBU
- Website: cariboubio.com
- Phone: 510-982-6030
Industries & Categories
Biotechnology, Health Care, Oncology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/caribou-biosciences-31984 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.